Skip to main content
Caplight Logo









Cell4Cure AB

Cell4Cure AB

Private
SolnaHealthcare & Life Scienceshttps://www.cell4cure.com/

Company Overview

Cell4Cure AB is a biotechnology company that develops autologous cell-based therapies for immune tolerance induction to treat autoimmune diseases and anti-drug antibodies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapydendritic cellsimmune tolerancetolerogenic dendritic cellstolDCautologous cell therapyex vivo engineeringbiotechimmunotherapyautoimmune disease treatmenttransplant rejectionhemophilia Aclinical-stage biotechnext-gen immunotherapyprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cell4Cure AB Comparables

Compare Cell4Cure AB with similar companies based on industry and business-model similarity.

Cell4Cure AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rezq Bio
86%
TolerogenixX GmbH
81%
Anokion
77%

Cell4Cure AB Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Cell4Cure AB Filings

Explore SEC and related filing metadata, where available.

Cell4Cure AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cell4Cure AB's valuation, stock price, and market status.

Is Cell4Cure AB a public or private company?

Cell4Cure AB is a private company.

What is the current stock price of Cell4Cure AB?

Cell4Cure AB is a private company with no public stock price. Caplight tracks Cell4Cure AB's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Cell4Cure AB worth (valuation)?

Valuation information for Cell4Cure AB is not publicly available.

Can I buy Cell4Cure AB stock?

Cell4Cure AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cell4Cure AB's last funding round?

Funding round information for Cell4Cure AB is not publicly available.

Who are the main investors in Cell4Cure AB?

Investor information for Cell4Cure AB is not publicly disclosed.

Will Cell4Cure AB IPO soon?

No public IPO plans have been announced for Cell4Cure AB.

How can I track Cell4Cure AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cell4Cure AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSolna
Employee Range3
Year Founded2023
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?